胎儿生理药代动力学模型:胎儿生物测量与大体成分的系统信息
本研究通过系统文献检索和荟萃分析,整合了97篇出版物中胎儿体重、身高、体表面积、体脂和体水等生物测量数据,建立了描述胎儿生长随孕龄变化的数学算法,为构建胎儿生理药代动力学模型的 anthropometric 特征提供资源。
要点
- 整合97篇文献的胎儿生物测量数据,覆盖体重、身高、体表面积、体脂和体水等参数。
- 通过荟萃分析开发数学算法,描述从受孕到出生的胎儿参数变化。
- 所建函数可用于胎儿生理药代动力学模型的人体测量学特征构建。
核心结论
- 汇集的胎儿生物测量数据支持建立数学函数以描述胎儿生长,为胎儿生理药代动力学模型提供人体测量学资源。
研究设计与样本
- 研究为系统文献检索与荟萃分析,数据来自97篇出版物。
主要发现
- 数据来源中,15篇与胎儿身高或长度相关,32篇与胎儿体重相关,4篇与胎儿体表面积相关。
- 8篇与冠臀长相关,5篇与腹围相关,12篇与头围相关,14篇与体脂相关,12篇与体水相关。
- 需要多种数学算法来描述从受孕到出生期间的参数值。
临床怎么用
- 所开发的数学函数可作为构建胎儿生理药代动力学模型人体测量学特征的资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postulating fetal exposure to xenobiotics has been based on animal studies; however, inter-species differences can make this problematic. Physiologically-based pharmacokinetic models may capture the rapid changes in anatomical, biochemical, and physiological parameters during fetal growth over the duration of pregnancy and help with interpreting laboratory animal data. However, these models require robust information on the longitudinal variations of system parameter values and their covariates. OBJECTIVE: The objective of this study was to present an extensive analysis and integration of the available biometric data required for creating a virtual human fetal population by means of equations that define the changes of each parameter with gestational age. METHODS: A comprehensive literature search was carried out on the parameters defining the growth of a fetus during in-utero life including weight, height, and body surface area in addition to other indices of fetal size, body fat, and water. Collated data were assessed and integrated through a meta-analysis to develop mathematical algorithms to describe growth with fetal age. RESULTS: Data for the meta-analysis were obtained from 97 publications, of these, 15 were related to fetal height or length, 32 to fetal weight, 4 to fetal body surface area, 8 to crown length, 5 to abdominal circumference, 12 to head circumference, 14 to body fat, and 12 to body water. Various mathematical algorithms were needed to describe parameter values from the time of conception to birth. CONCLUSION: The collated data presented in this article enabled the development of mathematical functions to describe fetal biometry and provide a potentially useful resource for building anthropometric features of fetal physiologically-based pharmacokinetic models.
引用
- Abduljalil K, Johnson TN, Rostami-Hodjegan A, et al. Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross Composition. Clin Pharmacokinet. 2018. PMID: 29264787. doi:10.1007/s40262-017-0618-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。